1 |
Zhang J,Yi Q,Zhou C,et al.Characteristics,treatments,in-hospital and long-term outcomes among inpatients with acute exacerbation of chronic obstructive pulmonary disease in China: sex differences in a large cohort study[J].BMC Pulm Med,2024,24(1): 125-135.
|
2 |
任成山,王关嵩,钱桂生.慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD].中华肺部疾病杂志(电子版),2019,12(2): 127-141.
|
3 |
Liew CQ,Hsu SH,Ko CH,et al.Acute exacerbation of chronic obstructive pulmonary disease in United States emergency departments,2010-2018[J].BMC Pulm Med,2023,23(1):217-226.
|
4 |
Caprino R,Sartori G,Sartori F,et al.Factors associated with risk of death in hospitalized patients for exacerbation of chronic obstructive pulmonary disease: an updated scoping review [J].Expert Rev Respir Med,2024,18(6): 435-445.
|
5 |
董毅娟.慢性阻塞性肺疾病急性加重期外周血嗜酸性粒细胞水平与细菌感染的关系[J].中国药物与临床,2021,21(18):3130-3132.
|
6 |
Sorge R,DeBlieux P.Acute exacerbations of chronic obstructive pulmonary disease: a primer for emergency physicians[J].J Emerg Med,2020,59(5): 643-659.
|
7 |
王怡洁,陈瑶君,罗嘉莹,等.嗜酸性粒细胞的生物学特征及其在变态反应性疾病中的作用[J].实用医学杂志,2022,38(5):633-637.
|
8 |
Lonergan M,Dicker AJ,Crichton ML,et al.Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD[J].Respir Res,2020,21(1): 166174.
|
9 |
Wang F,Yang L,Wang M,et al.Association between blood eosinophil count and bacterial infection and clinical outcomes in patients with severe exacerbations of chronic obstructive pulmonary disease[J].Chin Med J (Engl),2021,135(4): 462-464.
|
10 |
Kostikas K,Papathanasiou E,Papaioannou AI,et al.Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational study[J].Biomarkers,2021,26(4): 354-362.
|
11 |
程炜炜,张 青,张诚实,等.全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J/CD].中华肺部疾病杂志(电子版),2024,17(4): 580-584.
|
12 |
Yu S,Zhang J,Fang Q,et al.Blood eosinophil levels and prognosis of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease[J].Am J Med Sci,2021,362(1): 56-62.
|
13 |
Crisafulli E,Manco A,Guerrero M,et al.Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD[J].Intern Emerg Med,2021,16(2): 401-408.
|
14 |
Luo J,Zhang D,Tang W,et al.Impact of frailty on the risk of exacerbations and all-cause mortality in elderly patients with stable chronic obstructive pulmonary disease[J].Clin Interv Aging,2021,16: 593-601.
|
15 |
Sun W,Li Y,Tan S.Development and validation of an in-hospital mortality prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease[J].Int J Chron Obstruct Pulmon Dis,2024,19: 1303-1314.
|
16 |
Jordan A,Sivapalan P,Rømer V,et al.Time-updated phenotypic guidance of corticosteroids and antibiotics in COPD: rationale,perspective and a proposed method[J].Biomedicines,2023,11(5): 1395.
|
17 |
Kant A,Terzioglu K.Association of severity of allergic rhinitis with neutrophil-to-lymphocyte,eosinophil-to-neutrophil,and eosinophilto-lymphocyte ratios in adults[J].Allergol Immunopathol (Madr),2021,49(5): 94-99.
|
18 |
Selçuk A,Keren M.The evaluation of eosinophil-to-lymphocyte,eosinophil-toneutrophil,and neutrophil-to-lymphocyte ratios in adults with allergic/non-allergic rhinitis[J].Evaluation,2023,65(1): 51-55.
|
19 |
Gao J,Chen B,Wu S,et al.Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations[J].BMC Pulm Med,2020,20(1): 50-57.
|
20 |
Kraus RF,Gruber M A.Neutrophils-from bone marrow to first-line defense of the innate immune system[J].Front Immunol,2021,12: 767175.
|
21 |
Lehman HK,Segal BH.The role of neutrophils in host defense and disease[J].J Allergy Clin Immunol,2020,145(6): 1535-1544.
|
22 |
Jackson DJ,Akuthota P,Roufosse F.Eosinophils and eosinophilic immune dysfunction in health and disease[J].? Eur Respir Rev,2022,31(163): 210150-210162.
|
23 |
Ondari E,Calvino-Sanles E,First NJ,et al.Eosinophils and bacteria,the beginning of a story[J].Int J Mol Sci,2021,22(15): 8004-8020.
|
24 |
Wu C.Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma[J].Open Life Sci,2023,18(1):20220779.
|
25 |
Gaur P,Zaffran I,George T,et al.The regulatory role of eosinophils in viral,bacterial,and fungal infections[J].Clin Exp Immunol,2022,209(1): 72-82.
|
26 |
D’Anna SE,Maniscalco M,Cappello F,et al.Bacterial and viral infections and related inflammatory responses in chronic obstructive pulmonary disease[J].Ann Med,2021,53(1): 135-150.
|
27 |
Rodrigues SO,Cunha CMC,Soares GMV,et al.Mechanisms,pathophysiology and currently proposed treatments of chronic obstructive pulmonary disease[J].Pharmaceuticals(Basel),2021,14(10): 979-1009.
|
28 |
Ham J,Kim J,Ko YG,et al.The dynamic contribution of neutrophils in the chronic respiratory diseases[J].Allergy Asthma Immunol Res,2022,14(4): 361-378.
|
29 |
Bedolla-Barajas M,Morales-Romero J,Hernández-Colín DD,et al.Beyond eosinophilia: inflammatory patterns in patients with asthma[J].J Asthma,2022,59(2): 255-263.
|
30 |
Crocetto F,Imbimbo C,Barone B,et al.Which inflammatory marker,between systemic immune-inflammation index and neutrophil to eosinophil ratio,is associated with Peyronie’s disease and are there any implications for a better understanding of its mechanisms? [J].Basic Clin Androl,2023,33(1): 38.
|